As expected, the expression of SF3B1 was markedly increased in ovarian cancer (Fig. 1g, h), and high levels of SF3B1 were correlated with poor PFS (Fig. 1i) and overall survival (Fig. 1j). This evidence concerns the gene SF3B1 and ovarian carcinoma.